September 2025
1. ANZELLINI D, Loddo M, Del Bianco S
   Long-lasting Complete Remission Following Immunotherapy With Anti-PD1 Plus Anti-CTLA4 in a Polymetastatic Patient With NRAS (Q16R) Mutated Anaplastic Thyroid Carcinoma.
   Anticancer Res. 2025;45:3809-3816.
   

   >> Share

   
   April 2025
2. HAYASHI K, Ishida K, Kato M, Ohkubo S, et al
   Activation of DCTN1-RET Fusion Through Coiled-coil Domain as a Potential Target for RET Inhibitors.
   Anticancer Res. 2025;45:1407-1417.
   

   >> Share

   
   December 2024
3. BOWERS JC, Savaliya BP, Raikot SR, Ahmed SH, et al
   Survival Outcomes and Disparities in Surgery Refusal for Papillary Thyroid Cancer.
   Anticancer Res. 2024;44:5455-5461.
   

   >> Share

   
   October 2024
4. MIYAKE R, Takeyama H, Manome Y, Koyama M, et al
   Thyroid Cancer With Autocrine Sialyl-fibronectin Depletion Has a Poor Prognosis due to EMT Progression.
   Anticancer Res. 2024;44:4561-4568.
   

   >> Share

   
   
5. NA YM, Park SC, An SY, Ma HU, et al
   Analysis of Initial Outcomes of Gas-insufflation One-step Single-port Transaxillary (GOSTA) Robotic Thyroidectomy for Thyroid Cancer.
   Anticancer Res. 2024;44:4585-4592.
   

   >> Share

   
   July 2024
6. TODA S, Saito N, Kadoya M, Okubo Y, et al
   Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma.
   Anticancer Res. 2024;44:3141-3147.
   

   >> Share

   
   May 2024
7. JI N, Lee Y, Lee SH, Kim HS, et al
   Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
   Anticancer Res. 2024;44:2159-2170.
   

   >> Share

   
   January 2024
8. YOSHIMURA N, Fujiwara M, Igeta M, Suzuki H, et al
   Risk Factors Causing Hypothyroidism in Patients With Head and Neck Cancer After Radiotherapy Using SIB-VMAT.
   Anticancer Res. 2024;44:323-329.
   

   >> Share

   
   November 2023
9. KOWKABANY G, Jimenez PB, Sharan S, Bansal S, et al
   Inequities in Time to Treat Thyroid Cancer.
   Anticancer Res. 2023;43:5025-5030.
   

   >> Share

   
   October 2023
10. ZHOU J, Liu J, Zhang KE, Lv J, et al
    High-throughput Sequencing Analysis of Differentially Expressed microRNAs Associated With SREBP1 in Differentiated Thyroid Carcinoma.
    Anticancer Res. 2023;43:4435-4446.
    

    >> Share

    
    April 2023
11. LANDSTROM F, Sandberg J, Reizenstein J
    Life-threatening Airway Complication After Radioactive Iodine Treatment: A Case Report and Review of the Literature.
    Anticancer Res. 2023;43:1853-1855.
    

    >> Share

    
    March 2023
12. NAKAYAMA H, Saito N, Kasajima R, Suganuma N, et al
    Validation of EZH2 Inhibitor Efficiency in Anaplastic Thyroid Carcinoma Cell Lines.
    Anticancer Res. 2023;43:1073-1077.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share